'Off pump' self-expanding injectable tissue valves (IPVR) versus 'on pump' conventional tissue valves (PVR) for replacement of the pulmonary valve: trial protocol for a randomised controlled trial (InVITe trial)

Rachael Heys, Gianni Angelini, Massimo Caputo, Lucy Culliford, Maria Pufulete, Barnaby Reeves, Chris Rogers, Serban Stoica, Andrew Parry*

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)

153 Downloads (Pure)

Abstract

Introduction: Patients with congenital heart disease often need repeated operations throughout life to replace the pulmonary valve. Valve replacement with ‘injectable’ self-expanding valves (which is performed ‘off pump’; without the use of cardiopulmonary bypass, CPB) may result in quicker recovery and lower risk of major complications than valve replacement with conventional valves (which is performed ‘on pump’, with the use of CPB).

Methods and analysis:
We are conducting a multi-centre, single-blind randomised controlled trial in patients aged between 12 and 80 years with congenital heart disease. We will randomise participants in a 1:1 ratio to receive either ‘off pump’ injectable pulmonary valve replacement or ‘on pump’ conventional pulmonary valve replacement. The primary outcome will be the difference between groups with respect to post-surgery blood loss (as measured by chest drain volume) in the first 24 hours. Secondary outcomes will include in-hospital outcomes (intensive care unit stay; inotropic/vasodilator support; chest drain volume in the first 12 hours post-surgery; time of readiness for extubation; blood products used in the first 24 hours post-surgery; time of fitness for discharge); valve and heart function 6 months post-surgery (assessed using cardiovascular magnetic resonance and echocardiography); and health related quality of life 6 weeks and 6 months post-surgery.

Ethics and dissemination: This trial has been approved by the South West – Exeter Research Ethics Committee. Findings will be shared with participating hospitals and disseminated to the academic community through peer reviewed publications and presentation at national and international meetings. Patients will be informed of the results through patient organisations and newsletters to participants.

Trial registration: ISRCTN registry, identifier ISRCTN23538073. Registered on 20/01/2016.
Original languageEnglish
Article numbere026221
Number of pages7
JournalBMJ Open
Volume9
Issue number4
Early online date2 Apr 2019
DOIs
Publication statusPublished - Apr 2019

Bibliographical note

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Structured keywords

  • BTC (Bristol Trials Centre)

Keywords

  • cardiac surgery
  • congenital heart disease
  • valvular heart disease

Fingerprint Dive into the research topics of ''Off pump' self-expanding injectable tissue valves (IPVR) versus 'on pump' conventional tissue valves (PVR) for replacement of the pulmonary valve: trial protocol for a randomised controlled trial (InVITe trial)'. Together they form a unique fingerprint.

  • Cite this